Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

被引:0
|
作者
Natasha Leigh
Daniel Solomon
Eric Pletcher
Daniel M. Labow
Deepa R. Magge
Umut Sarpel
Benjamin J. Golas
机构
[1] Icahn School of Medicine at Mount Sinai St. Luke’s West Hospital,Division of Surgical Oncology
关键词
Peritoneal carcinomatosis; Hyperthermic intraperitoneal chemotherapy; Cytoreductive surgery; Hepatocellular carcinoma; Hepatobiliary malignancy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Robotic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is there a benefit?
    Sparkman, Brian K.
    Freudenberger, Devon C.
    Vudatha, Vignesh
    Trevino, Jose G.
    Khader, Adam
    Fernandez, Leopoldo J.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2025, 39 (01): : 513 - 521
  • [22] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer
    Newman, N. A.
    Votanopoulos, K. I.
    Stewart, J. H.
    Shen, P.
    Levine, E. A.
    MINERVA CHIRURGICA, 2012, 67 (04) : 309 - 318
  • [23] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Where are we?
    Koenigsrainer, Ingmar
    Beckert, Stefan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (38) : 5317 - 5320
  • [24] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
    Gamboa, Adriana C.
    Winer, Joshua H.
    CANCERS, 2019, 11 (11)
  • [25] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
    Khan, Hadi M.
    Hanif, Hamza
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (02): : 259 - 261
  • [26] Peritoneal sarcomatosis: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Spiliotis, John
    Kopanakis, Nikolaos
    Prodromidou, Anastasia
    Raptis, Apostolos
    Farmakis, Dimitrios
    Efstathiou, Elias
    SURGICAL INNOVATION, 2021, 28 (03) : 394 - 395
  • [27] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer
    Schmalfeldt, Barbara
    CHIRURGIE, 2022, 93 (12): : 1144 - 1151
  • [28] Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies
    Somashekhar, S. P.
    Yethadka, Ramya
    Kumar, Rohit C.
    Ashwin, K. R.
    Zaveri, Shabber
    Rauthan, Amit
    EJSO, 2020, 46 (04): : 577 - 581
  • [29] Incidence and Predictors of Incisional Hernia After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancies
    Huang, J.
    Kizy, S.
    Altman, A. M.
    Nalluri, H.
    Marmor, S.
    Gaertner, W.
    Jensen, E. H.
    Hui, J.
    Tuttle, T. M.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S142 - S142
  • [30] Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Chia, C. S.
    Tan, W. J.
    Wong, J. F. Sze
    Tan, G. H. Ching
    Lim, C.
    Wang, W.
    Sin, E. I. -L.
    Tham, C. K.
    Soo, K. C.
    Teo, M. C. C.
    EJSO, 2014, 40 (08): : 909 - 916